A blog about chemistry, drug development, science, and technology
Seems my old company is now paying $10.5 million to resolve claims that they were promoting Trisenox for uses that were not approved.
Cell Therapeutics to pay $10.5 million:
I always thought they were leaving them selves open for this sort of problems back when I was working for them given the huge amount of off-label use. When a huge portion of your drug is being used for diseases it isn’t approved for, you are going to raise some eyebrows.
I should note that “Cell Therapeutics does not admit any wrongdoing in the matter”. And we all know what that really means.
Technorati Tags: CEll THerapeutics
Bookmark it with:
|
del.icio.us
|
Digg it
|
Furl
|
Simpy
|
Spurl
|
My Yahoo!
|
[powered by WordPress.]
QDIS: blogging about chemistry, drug development, science and technology.

By Category
Chemistry, science, and technology for the future.

35 queries. 1.016 seconds